Martine Zimmermann sold $342K of Ligand Pharmaceuticals Incorporated (LGND)

Executed Sep 10, disclosed Sep 14, 4 days later.

Value, as filed

$342K

1,200 sh × $285.00

Executed

Sep 10

the trade date, as filed

Disclosed

Sep 14

4 days after the trade

Return, 21 sessionsiFrom the disclosed entry session; derived

–

purchases only

Returns are measured on stock purchases only.

The filer

Martine Zimmermann Director profile →

Martine Zimmermann (Director) filed 1 Form 4 report in the trailing twelve months (0 purchases, 1 sale), most often in Ligand Pharmaceuticals Incorporated (LGND). The largest single filing was $342K of LGND (1,200 sh × $285.00, as filed), executed Sep 10.

The name

LGND

Ligand Pharmaceuticals Incorporated LGND · Healthcare · 36 filings in 24 months ticker →

Healthcare · Ligand Pharmaceuticals Incorporated, a biopharmaceutical company, develops and licenses biopharmaceutical assets worldwide

More Healthcare filings→ Insider filings, newest first→ View the original filing at www.sec.gov→